The Application of Intense Therapeutic Ultrasound in Plantar Fasciitis. A Randomized, Non-probabilistic and Superiority Controlled Clinical Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Plantar Fasciitis
- Sponsor
- Universidad Complutense de Madrid
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Pain reduction
- Last Updated
- 6 years ago
Overview
Brief Summary
It was previously hypothesized that patients receiving Intense Therapeutic Ultrasound (ITU) in addition to the standard of care would have a more rapid resolution of pain, faster return to activities, and a decrease in intra- and perifascial lesions.
Detailed Description
Intense Therapeutic Ultrasound (ITU) is an established ultrasound-based therapy in which sound waves are concentrated and focused into a well-defined specific area of musculoskeletal tissue. Previous researches hipothesize that the application of ITU improve and accelerate healing in patients with chronic plantar fasciitis.
Investigators
Raúl Juan Molines Barroso, Phd
Clinical Professor
Universidad Complutense de Madrid
Eligibility Criteria
Inclusion Criteria
- •Both sex patients.
- •Plantar fasciitis diagnosis: pain during walking during the first steps in the morning; pain due to palpation of plantar fasciia insertion.
- •Chronic pain of at least 6 month.
- •Longitudinal thickness of the plantar fasciia more than 4 millimeters.
- •No previous surgery in the plantar fasciia.
- •No previous application of alternative treatments such us shock waves or injections (last ninety days)
Exclusion Criteria
- •Platelet count disorder or anticoagulation therapy.
- •Anti-inflammatories usual treatment for the treatment of plantar fasciitis.
- •Diabetic foot syndrome.
- •Presence of metabolic disease such us: hypertension, hiper or hipothyroidism.
- •Pregnancy or breastfeeding.
- •Previous treatment with fluoroquinolones antibiotic.
- •Bilateral plantar fasciitis.
- •Diagnosed Autoimmune disesase.
- •Morphofunctional disorders in the foot and ankle.
- •Diagnosed fibromyalgia.
Outcomes
Primary Outcomes
Pain reduction
Time Frame: 24 weeks
Use of a Subjective Visual Analogue Scale (SVAS): the outmost left (0 cm) was labelled pain absence and the outmost right (10 cm) was labelled the maximum imagined pain.
Plantar fasciia thickness reduction
Time Frame: 24 weeks
Longitudinal view of the plantar fasciia with the use of ultrasound probe.
Secondary Outcomes
- Hypoechoic volume area reduction(24 weeks)
- Ankle range of motion reduction(24 weeks)
- Time to incorporation to daily live activities(24 weeks)
- Autonomous gait without pain in the heel(24 weeks)
- Improvement of patients satisfaction(24 weeks)